{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:54:37Z","timestamp":1764791677314,"version":"3.46.0"},"reference-count":19,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>The significance of positive immunoglobulin (IG) or T-cell receptor (TCR) gene rearrangement studies in the context of otherwise normal ancillary findings is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To examine long-term hematologic outcomes of individuals with positive gene rearrangement studies with otherwise unremarkable blood or bone marrow studies in parallel.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>Data from patients who underwent IG or TCR gene rearrangement testing at the authors' affiliated Veterans Affairs Hospital January 1, 2013 to July 6, 2018 were extracted from medical records. Date of testing, specimen source, and morphologic, flow cytometric, immunohistochemical, and cytogenetic characterization of the tissue source were recorded. Gene rearrangement results were categorized as test positive\/phenotype positive (T+\/P+), test positive\/phenotype negative (T+\/P\u2212), test negative\/phenotype negative (T\u2212\/P\u2212), or test negative\/phenotype positive (T\u2212\/P+) based on comparison to other studies and\/or final diagnosis. Patient records were reviewed for subsequent diagnosis of hematologic malignancy for patients with positive gene rearrangements but no other evidence for a disease process.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>A total of 136 patients with 203 gene rearrangement studies were analyzed. For TCR studies, there were 2 T+\/P\u2212 and 1 T\u2212\/P+ results in 47 peripheral blood assays, as well as 7 T+\/P\u2212 and 1 T\u2212\/P+ results in 54 bone marrow assays. Regarding IG studies, 3 T+\/P\u2212 and 12 T\u2212\/P+ results in 99 bone marrow studies were identified. None of the 12 patients with T+\/P\u2212 TCR or IG gene rearrangement studies later developed a lymphoproliferative disorder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>Positive IG\/TCR gene rearrangement studies in the context of otherwise negative bone marrow or peripheral blood findings are not predictive of lymphoproliferative disorders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2019-0663-oa","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T10:51:12Z","timestamp":1596192672000},"page":"227-230","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Positive B- and T-Cell Gene Rearrangement Studies in Patients With Negative Morphology, Flow Cytometry, and Immunohistochemistry"],"prefix":"10.5858","volume":"145","author":[{"given":"Hadrian","family":"Mendoza","sequence":"first","affiliation":[{"name":"The Department of Laboratory Medicine (Mendoza, Tormey, Siddon), New Haven, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Tormey","sequence":"additional","affiliation":[{"name":"The Department of Laboratory Medicine (Mendoza, Tormey, Siddon), New Haven, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexa J.","family":"Siddon","sequence":"additional","affiliation":[{"name":"The Department of Laboratory Medicine (Mendoza, Tormey, Siddon), New Haven, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Pathology (Siddon), Yale School of Medicine, New Haven, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","published-online":{"date-parts":[[2020,7,31]]},"reference":[{"key":"2021012621544910800_i1543-2165-145-2-227-b01","doi-asserted-by":"crossref","unstructured":"Woo\n              J,\n            \n            \n              Baumann\n              A,\n            \n            \n              Arguello\n              V.\n            \n          \n          Recent advancements of flow cytometry: new applications in hematology and oncology.\n\t\t\t\t\tExpert Rev Mol Diagn.\n\t\t\t\t\t2014;\n\t\t\t\t\t14(1):\n\t\t\t\t\t67\u2013\n\t\t\t\t\t81.","DOI":"10.1586\/14737159.2014.862153"},{"key":"2021012621544910800_i1543-2165-145-2-227-b02","doi-asserted-by":"crossref","unstructured":"van Krieken\n              JH,\n            \n            \n              Langerak\n              AW,\n            \n            \n              Macintyre\n              EA,\n            \n            et al.\n          \n          Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 concerted action BHM4-CT98-3936.\n\t\t\t\t\tLeukemia.\n\t\t\t\t\t2007;\n\t\t\t\t\t21(2):\n\t\t\t\t\t201\u2013\n\t\t\t\t\t206.","DOI":"10.1038\/sj.leu.2404467"},{"key":"2021012621544910800_i1543-2165-145-2-227-b03","doi-asserted-by":"crossref","unstructured":"Fan\n              H,\n            \n            \n              Robertorye\n              RS.\n            \n          \n          Detection of clonal immunoglobulin heavy chain gene rearrangements by the polymerase chain reaction and capillary gel electrophoresis.\n\t\t\t\t\tIn:CazaderM,ed.Hematological Malignancies: Methods and Protocols.\n\t\t\t\t\tNew York:\n\t\t\t\t\tHumana Press;2013:\n\t\t\t\t\t151\u2013\n\t\t\t\t\t167.","DOI":"10.1007\/978-1-62703-357-2_10"},{"key":"2021012621544910800_i1543-2165-145-2-227-b04","doi-asserted-by":"crossref","unstructured":"Fan\n              H,\n            \n            \n              Robertorye\n              RS.\n            \n          \n          Detection of clonal T-cell receptor beta and gamma chain gene rearrangement by polymerase chain reaction and capillary gel electrophoresis.\n\t\t\t\t\tIn:CzaderM,ed.Hematological Malignancies: Methods and Protocols.\n\t\t\t\t\tNew York:\n\t\t\t\t\tHumana Press;2013:\n\t\t\t\t\t169\u2013\n\t\t\t\t\t188.","DOI":"10.1007\/978-1-62703-357-2_11"},{"key":"2021012621544910800_i1543-2165-145-2-227-b05","doi-asserted-by":"crossref","unstructured":"van Dongen\n              JJ,\n            \n            \n              Langerak\n              AW,\n            \n            \n              Bruggemann\n              M,\n            \n            et al.\n          \n          Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.\n\t\t\t\t\tLeukemia.\n\t\t\t\t\t2003;\n\t\t\t\t\t17(12):\n\t\t\t\t\t2257\u2013\n\t\t\t\t\t2317.","DOI":"10.1038\/sj.leu.2403202"},{"key":"2021012621544910800_i1543-2165-145-2-227-b06","doi-asserted-by":"crossref","unstructured":"Langerak\n              AW,\n            \n            \n              Groenen\n              PJ,\n            \n            \n              Bruggemann\n              M,\n            \n            et al.\n          \n          EuroClonality\/BIOMED-2 guidelines for interpretation and reporting of Ig\/TCR clonality testing in suspected lymphoproliferations.\n\t\t\t\t\tLeukemia.\n\t\t\t\t\t2012;\n\t\t\t\t\t26(10):\n\t\t\t\t\t2159\u2013\n\t\t\t\t\t2171.","DOI":"10.1038\/leu.2012.246"},{"key":"2021012621544910800_i1543-2165-145-2-227-b07","doi-asserted-by":"crossref","unstructured":"Langerak\n              AW,\n            \n            \n              Molina\n              TJ,\n            \n            \n              Lavender\n              FL,\n            \n            et al.\n          \n          Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls. A report of the BIOMED-2 concerted action BMH4-CT98-3936.\n\t\t\t\t\tLeukemia.\n\t\t\t\t\t2007;\n\t\t\t\t\t21(2):\n\t\t\t\t\t222\u2013\n\t\t\t\t\t229.","DOI":"10.1038\/sj.leu.2404482"},{"key":"2021012621544910800_i1543-2165-145-2-227-b08","doi-asserted-by":"crossref","unstructured":"Evans\n              PA,\n            \n            \n              Pott\n              C,\n            \n            \n              Groenen\n              PJ,\n            \n            et al.\n          \n          Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 concerted action BHM4-CT98-3936.\n\t\t\t\t\tLeukemia.\n\t\t\t\t\t2007;\n\t\t\t\t\t21(2):\n\t\t\t\t\t207\u2013\n\t\t\t\t\t214.","DOI":"10.1038\/sj.leu.2404479"},{"key":"2021012621544910800_i1543-2165-145-2-227-b09","doi-asserted-by":"crossref","unstructured":"Hodges\n              E,\n            \n            \n              Krishna\n              MT,\n            \n            \n              Pickard\n              C,\n            \n            \n              Smith\n              JL.\n            \n          \n          Diagnostic role of tests for T cell receptor (TCR) genes.\n\t\t\t\t\tJ Clin Pathol.\n\t\t\t\t\t2003;\n\t\t\t\t\t56(1):\n\t\t\t\t\t1\u2013\n\t\t\t\t\t11.","DOI":"10.1136\/jcp.56.1.1"},{"key":"2021012621544910800_i1543-2165-145-2-227-b10","doi-asserted-by":"crossref","unstructured":"Bekkenk\n              MW,\n            \n            \n              Geelen\n              FA,\n            \n            \n              van Voorst Vader\n              PC,\n            \n            et al.\n          \n          Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment.\n\t\t\t\t\tBlood.\n\t\t\t\t\t2000;\n\t\t\t\t\t95(12):\n\t\t\t\t\t3653\u2013\n\t\t\t\t\t3661.","DOI":"10.1182\/blood.V95.12.3653"},{"key":"2021012621544910800_i1543-2165-145-2-227-b11","doi-asserted-by":"crossref","unstructured":"Sarzotti\n              M,\n            \n            \n              Patel\n              DD,\n            \n            \n              Li\n              X,\n            \n            et al.\n          \n          T cell repertoire development in humans with SCID after nonablative allogeneic marrow transplantation.\n\t\t\t\t\tJ Immunol.\n\t\t\t\t\t2003;\n\t\t\t\t\t170(5):\n\t\t\t\t\t2711\u2013\n\t\t\t\t\t2718.","DOI":"10.4049\/jimmunol.170.5.2711"},{"key":"2021012621544910800_i1543-2165-145-2-227-b12","doi-asserted-by":"crossref","unstructured":"Mariani\n              S,\n            \n            \n              Coscia\n              M,\n            \n            \n              Even\n              J,\n            \n            et al.\n          \n          Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion.\n\t\t\t\t\tBr J Haematol.\n\t\t\t\t\t2001;\n\t\t\t\t\t113(4):\n\t\t\t\t\t1051\u2013\n\t\t\t\t\t1059.","DOI":"10.1046\/j.1365-2141.2001.02871.x"},{"key":"2021012621544910800_i1543-2165-145-2-227-b13","doi-asserted-by":"crossref","unstructured":"Lee\n              SC,\n            \n            \n              Berg\n              KD,\n            \n            \n              Racke\n              FK,\n            \n            \n              Griffin\n              CA,\n            \n            \n              Eshleman\n              JR.\n            \n          \n          Pseudo-spikes are common in histologically benign lymphoid tissues.\n\t\t\t\t\tJ Mol Diagn.\n\t\t\t\t\t2000;\n\t\t\t\t\t2(3):\n\t\t\t\t\t145\u2013\n\t\t\t\t\t152.","DOI":"10.1016\/S1525-1578(10)60630-7"},{"key":"2021012621544910800_i1543-2165-145-2-227-b14","doi-asserted-by":"crossref","unstructured":"Dunlap\n              JB,\n            \n            \n              Fan\n              G,\n            \n            \n              Leeborg\n              N,\n            \n            \n              Braziel\n              RM.\n            \n          \n          B-Cell Malignancies.\n\t\t\t\t\tIn:LeonardDGB,ed.Molecular Pathology in Clinical Practice. 2nd ed.\n\t\t\t\t\tSwitzerland:\n\t\t\t\t\tSpringer International Publishing;2016:\n\t\t\t\t\t579\u2013\n\t\t\t\t\t602.","DOI":"10.1007\/978-3-319-19674-9_42"},{"key":"2021012621544910800_i1543-2165-145-2-227-b15","doi-asserted-by":"crossref","unstructured":"Rajkumar\n              SV,\n            \n            \n              Dimopoulos\n              MA,\n            \n            \n              Palumbo\n              A,\n            \n            et al.\n          \n          International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.\n\t\t\t\t\tLancet Oncol.\n\t\t\t\t\t2014;\n\t\t\t\t\t15(12):\n\t\t\t\t\te538\u2013\n\t\t\t\t\te548.","DOI":"10.1016\/S1470-2045(14)70442-5"},{"key":"2021012621544910800_i1543-2165-145-2-227-b16","doi-asserted-by":"crossref","unstructured":"Mendoza\n              H,\n            \n            \n              Tormey\n              CA,\n            \n            \n              Siddon\n              AJ.\n            \n          \n          Use of B-cell gene rearrangement studies to establish clonality in non-producer non-secretory multiple myeloma.\n\t\t\t\t\tClin Lymphoma Myeloma Leuk.\n\t\t\t\t\t2020;\n\t\t\t\t\t20(1):\n\t\t\t\t\te18\u2013\n\t\t\t\t\te21.","DOI":"10.1016\/j.clml.2019.10.012"},{"key":"2021012621544910800_i1543-2165-145-2-227-b17","doi-asserted-by":"crossref","unstructured":"Payne\n              K,\n            \n            \n              Wright\n              P,\n            \n            \n              Grant\n              JW,\n            \n            et al.\n          \n          BIOMED-2 PCR assays for IGK gene rearrangements are essential for B-cell clonality analysis in follicular lymphoma.\n\t\t\t\t\tBr J Haematol.\n\t\t\t\t\t2011;\n\t\t\t\t\t155(1):\n\t\t\t\t\t84\u2013\n\t\t\t\t\t92.","DOI":"10.1111\/j.1365-2141.2011.08803.x"},{"key":"2021012621544910800_i1543-2165-145-2-227-b18","doi-asserted-by":"crossref","unstructured":"Kokovic\n              I,\n            \n          \n          Jezersek Novakovic B, Novakovic S. Diagnostic value of immunoglobulin kappa light chain gene rearrangement analysis in B-cell lymphomas.\n\t\t\t\t\tInt J Oncol.\n\t\t\t\t\t2015;\n\t\t\t\t\t46(3):\n\t\t\t\t\t953\u2013\n\t\t\t\t\t962.","DOI":"10.3892\/ijo.2014.2790"},{"key":"2021012621544910800_i1543-2165-145-2-227-b19","doi-asserted-by":"crossref","unstructured":"Langerak\n              AW.\n            \n          \n          Undersized, oversized? It is not one-size-fits-all in lymphoid clonality detection.\n\t\t\t\t\tLeuk Res.\n\t\t\t\t\t2008;\n\t\t\t\t\t32(2):\n\t\t\t\t\t203\u2013\n\t\t\t\t\t204.","DOI":"10.1016\/j.leukres.2007.07.005"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/145\/2\/227\/2715944\/i1543-2165-145-2-227.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/145\/2\/227\/2715944\/i1543-2165-145-2-227.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:40:50Z","timestamp":1764790850000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/145\/2\/article-p227.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,31]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,7,31]]},"published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2019-0663-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"type":"electronic","value":"1543-2165"},{"type":"print","value":"0003-9985"}],"subject":[],"published":{"date-parts":[[2020,7,31]]}}}